Evidence map›Paper›PMID 40112032›Full record

ArticleeLife2025

The domesticated transposon protein L1TD1 associates with its ancestor L1 ORF1p to promote LINE-1 retrotransposition.

Gülnihal Kavaklioglu, Alexandra Podhornik, Terezia Vcelkova, Jelena Marjanovic, Mirjam A Beck, Trinh Phan-Canh, Theresia Mair, Claudia Miccolo, Aleksej Drino, Mirko Doni and 4 more

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Gülnihal KavakliogluDivision of Cell and Developmental Biology, Center for Anatomy and Cell Biology, Medical University of Vienna, Vienna, Austria.
Alexandra PodhornikDivision of Cell and Developmental Biology, Center for Anatomy and Cell Biology, Medical University of Vienna, Vienna, Austria.
Terezia VcelkovaDivision of Cell and Developmental Biology, Center for Anatomy and Cell Biology, Medical University of Vienna, Vienna, Austria.
Jelena MarjanovicDivision of Cell and Developmental Biology, Center for Anatomy and Cell Biology, Medical University of Vienna, Vienna, Austria.
Mirjam A BeckDivision of Cell and Developmental Biology, Center for Anatomy and Cell Biology, Medical University of Vienna, Vienna, Austria.
Trinh Phan-CanhMedical University of Vienna, Max Perutz Labs Vienna, Campus Vienna Biocenter, Vienna, Austria.ORCID https://orcid.org/0000-0002-6399-0959
Theresia MairDepartment of Pathology, Medical University of Vienna, Vienna, Austria.
Claudia MiccoloDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Aleksej DrinoDivision of Cell and Developmental Biology, Center for Anatomy and Cell Biology, Medical University of Vienna, Vienna, Austria.
Mirko DoniDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Gerda EggerDepartment of Pathology, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0003-2489-155X
Susanna ChioccaDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Miha ModicNational Institute of Chemistry, Ljubljana, Slovenia.
Christian SeiserDivision of Cell and Developmental Biology, Center for Anatomy and Cell Biology, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-7046-9352

Funding

Austrian Research Promotion Agency Bridge Early Phase project 5722451Austrian Science Fund 10.55776/P34998Austrian Science Fund DOC32Austrian Science Fund DOC59Austrian-South-East Asian Academic University Network Ernst Mach Grant
6 · The paper itself

Abstract

Repression of retrotransposition is crucial for the successful fitness of a mammalian organism. The domesticated transposon protein L1TD1, derived from LINE-1 (L1) ORF1p, is an RNA-binding protein that is expressed only in some cancers and early embryogenesis. In human embryonic stem cells, it is found to be essential for maintaining pluripotency. In cancer, L1TD1 expression is highly correlative with malignancy progression and as such considered a potential prognostic factor for tumors. However, its molecular role in cancer remains largely unknown. Our findings reveal that DNA hypomethylation induces the expression of L1TD1 in HAP1 human tumor cells. L1TD1 depletion significantly modulates both the proteome and transcriptome and thereby reduces cell viability. Notably, L1TD1 associates with L1 transcripts and interacts with L1 ORF1p protein, thereby facilitating L1 retrotransposition. Our data suggest that L1TD1 collaborates with its ancestral L1 ORF1p as an RNA chaperone, ensuring the efficient retrotransposition of L1 retrotransposons, rather than directly impacting the abundance of L1TD1 targets. In this way, L1TD1 might have an important role not only during early development but also in tumorigenesis.

Indexed as

Long Interspersed Nucleotide ElementsRNA-Binding ProteinsCell Line, TumorDNA MethylationHumansProtein BindingRetroelementsRibonucleoproteinsL1 ORF1 protein, humanRetroelementsRibonucleoproteinsRNA-Binding ProteinschromosomesDNA methylationevolutionary biologygene expressionhumanRNA-binding proteintransposons

Identifiers

PMID40112032
PMCPMC11925450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.